Mizuho Medy Co Ltd
TSE:4595
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
Mizuho Medy Co Ltd
TSE:4595
|
34.4B JPY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.1B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.1B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.9B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
40.1B USD |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Mizuho Medy Co Ltd is 29.1%, which is below its 3-year median of 34.6%.
Over the last 3 years, Mizuho Medy Co Ltd’s Net Margin has decreased from 43.4% to 29.1%. During this period, it reached a low of 29.1% on Oct 30, 2025 and a high of 44.6% on Dec 31, 2022.
